Acrivon Therapeutics, Inc. (ACRV)
(Real Time Quote from BATS)
$8.28 USD
-0.29 (-3.38%)
Updated May 23, 2024 12:44 PM ET
2-Buy of 5 2
D Value D Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/9/24 |
---|---|
Current Quarter | -0.59 |
EPS Last Quarter | -0.73 |
Last EPS Surprise | 17.98% |
ABR | 1.22 |
Earnings ESP
|
9.75% |
---|---|
Current Year | -2.47 |
Next Year | -2.55 |
EPS (TTM) | -2.88 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 3.09M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 3.09M |
Low Estimate | NA | NA | NA | 3.09M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.59 | -0.59 | -2.47 | -2.55 |
# of Estimates | 5 | 4 | 6 | 6 |
Most Recent Consensus | -0.48 | -0.49 | -2.25 | -3.14 |
High Estimate | -0.48 | -0.49 | -2.15 | -1.94 |
Low Estimate | -0.82 | -0.71 | -2.97 | -3.14 |
Year ago EPS | -0.63 | -0.66 | -2.74 | -2.47 |
Year over Year Growth Est. | 6.35% | 10.61% | 9.85% | -3.11% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 1 |
Up Last 30 Days | 3 | 3 | 6 | 5 |
Up Last 60 Days | 2 | 2 | 5 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.59 | -0.59 | -2.47 | -2.55 |
7 Days Ago | -0.62 | -0.59 | -2.61 | -2.62 |
30 Days Ago | -0.86 | -0.85 | -3.30 | -3.13 |
60 Days Ago | -0.82 | -0.89 | -2.98 | -2.88 |
90 Days Ago | -0.82 | -0.89 | -2.98 | -2.88 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.53 | -0.55 | -2.47 | -2.55 |
Zacks Consensus Estimate | -0.59 | -0.59 | -2.47 | -2.55 |
Earnings ESP | 9.75% | 6.61% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.73 | -0.86 | -0.66 | -0.63 | NA |
Estimate | -0.89 | -0.72 | -0.72 | -0.68 | NA |
Difference | 0.16 | -0.14 | 0.06 | 0.05 | 0.03 |
Surprise | 17.98% | -19.44% | 8.33% | 7.35% | 3.56% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more